A study led by researchers at the Hospital del Mar Medical Research Institute shows that the oxaliplatin administered in some…
Elena Élez
Published in Nature Medicine, a VHIO-led study has unveiled a new predictive biomarker of response to anti-BRAF/EGFR combinatory therapy in…
The multicenter randomized phase III BREAKWATER trial, spearheaded by VHIO, is the first to evaluate the combination of study drugs…
Promoted by the +MIR Spanish Society of Medical Oncology (SEOM) Residents and Young Oncologists Committee, a study published in ESMO…
